Hiraga, Nanaho
Ando, Yosuke https://orcid.org/0000-0001-8166-8165
Matsuoka, Hiroshi
Nishibe-Toyosato, Seira
Mizuno, Tomohiro
Katsuno, Hidetoshi
Ikeda, Yoshiaki
Kawada, Kenji
Morise, Zenichi
Suda, Koichi
Yamada, Shigeki
Funding for this research was provided by:
Kinjo Gakuin University
Article History
Received: 21 March 2025
Accepted: 24 May 2025
First Online: 5 June 2025
Declarations
:
: Yosuke Ando received honoraria for lectures from Chugai Pharm., Taiho Pharm., and Eisai and Takata Pharms. Kenji Kawada received honoraria for lectures from Novartis, Eisai and Chugai Pharm. Kenji Kawada received research funding from Chugai Pharm. and Abbott Japan LLC. Koichi Suda has no commercial or financial involvement construed as conflicts of interest regarding this article. Koichi Suda received funding from Sysmex Co. for the Collaborative Laboratory for Research and Development in Advanced Surgical Intelligence, Fujita Health University, outside this work. Koichi Suda also received research funding from Sysmex Co. and scholarship donations from Medicaroid, Inc., outside the submitted work.
: This study was approved by the Ethical Review Board of Fujita Health University (Approval Number: HM22-030). All procedures involving human participants were performed in accordance with the ethical standards of the institutional and/or national research committee and the 1964 Declaration of Helsinki, as revised in 2013, or with comparable ethical standards.
: This was a retrospective study. The need for informed consent was waived due to the use of an opt-out approach.